Mayo to hold trial for ALS stem cell therapy
Tel Aviv , March 18, 2013
BrainStorm Cell Therapeutics said the Mayo Clinic in Minnesota has agreed to conduct a clinical trial of the company's adult stem cell treatment for ALS.
The Mayo Clinic is the third leading US clinical site to sign a letter of understanding, following the University of Massachusetts and Massachusetts General, BrainStorm said on Monday.
Israel-based BrainStorm is developing NurOwn for the treatment of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's Disease, a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord.
Initial results from Phase I studies suggest that patients with ALS experience a positive clinical outcome after treatment with NurOwn cells, the company said.
Anthony Windebank, principal investigator at the Mayo Clinic, said the clinic started patient stem cell safety trials last year.
"The next logical ... step is the type of modification that enables BrainStorm's NurOwn cells to deliver factors to the nervous system that are known to promote motor nerve cell survival," Windebank said.
BrainStorm plans to enroll patients into clinical trials at the Mayo Clinic, the University of Massachusetts and Massachusetts General as early as the second half of 2013.
"This is another step forward in finding a potentially effective treatment option for those patients with ALS," said BrainStorm Chief Executive Alon Natanson.
BrainStorm will be presenting Phase 1 data of its NurOwn treatment in ALS at the annual meeting of the American Academy of Neurology on March 20.
According to the ALS Association, 5,600 people in the US are diagnosed each year with the disease, which has severely disabled British physicist Stephen Hawking. -Reuters
More Health & Environment Stories
- RAK Hospital launches urinary clinic for women
- NBAD backs Emiratis on Antarctica trip
- Cut sugar intake drastically urges WHO
- Al khaliji to fund Qatar recycling plant
- Qatar researcher in 360km breast cancer run
- New facilitator to open in DHCC
- Many countries lack capacity to prevent hearing loss
- QUIT NOW: Passive smoking hurts kids' arteries
- San Francisco to ban plastic water bottles
- GSK wins home toothpaste award for Sensodyne
- E-integration vital to GCC healthcare industry
- Fakih IVF unveils two new genetic tests
- 2 die from H1N1 in Oman
- Al Noor Hospitals targets domestic growth
- Medical panel on the way in Bahrain
- 40pc of UAE adults ‘have hypertension’
- Saudi diabetics urged to stay away from camels
- GCC readies plan to fight heart diseases
- Bahrain opens sickle cell hospital
- Hazardous waste focus for Oman summit
- Infectious viruses to be tracked by satellite in UAE
- Mafraq Hospital names new surgery chief
- Saudi health ministry seals BMJ partnership
- Need for medical simulation training highlighted
- UAE-France discuss healthcare collaboration
- Seha focus on patient centred services
- Saudi-Tokyo firms in wastewater technology JV
- Leading experts at Dubai diabetes conference
- UAE reliance on green energy on the rise
- DB unit backs therapeutic riding programme